| CLGEX | GFACX | CLGEX / GFACX | |
| Total Expense Ratio | 1.24 | 1.35 | 92% |
| Annual Report Gross Expense Ratio | 1.24 | 1.35 | 92% |
| Fund Existence | 19 years | 25 years | - |
| Gain YTD | 7.421 | 6.775 | 110% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 6.54B | 339B | 2% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 3.43 | 3.47 | 99% |
| Returns for 3 years | 82.08 | 56.11 | 146% |
| Returns for 5 years | 46.45 | 12.83 | 362% |
| Returns for 10 years | 123.64 | 74.12 | 167% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FRBRX | 182.96 | 1.29 | +0.71% |
| Franklin Biotechnology Discovery R6 | |||
| TSLRX | 5.32 | 0.02 | +0.38% |
| Transamerica Small Cap Value R6 | |||
| ALARX | 55.23 | 0.15 | +0.27% |
| Alger Capital Appreciation Instl I | |||
| JRAIX | 90.80 | 0.22 | +0.24% |
| Janus Henderson Research I | |||
| VAPPX | 24.15 | 0.03 | +0.12% |
| VALIC Company I Capital Appreciation | |||